Received Aug 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | ME6072 | IM / RL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | LX4486 | IM / LL |
Resident developed nausea and vomiting on 08/23/2025 at 1500, resident vomited x2 Ordered zofran from MD PRN. Resident still monitored every shift with no episodes noted for the ff shift. Resident still eating her meals for dinner and breakfast. Around shower time the next day resident noted to be non responsive while up on the shower chair. Transferred to bed, no vitals obtained. Resident is DNR.
n/a
END STAGE RENAL DISEASE CELLULITIS OF RIGHT UPPER LIMB PLEURAL EFFUSION, NOT ELSEWHERE CLASSIFIED TYPE 2 DIABETES MELLITUS WITH HYPERGLYCEMIA IMMUNODEFICIENCY DUE TO CONDITIONS CLASSIFIED ELSEWHERE ACUTE SYSTOLIC (CONGESTIVE) HEART FAILURE PAROXYSMAL ATRIAL FIBRILLATION ESSENTIAL (PRIMARY) HYPERTENSION HYPERLIPIDEMIA, UNSPECIFIED ANEMIA IN OTHER CHRONIC DISEASES CLASSIFIED ELSEWHERE GASTRO-ESOPHAGEAL REFLUX DISEASE WITHOUT ESOPHAGITIS DEPENDENCE ON RENAL DIALYSIS UNSPECIFIED ABNORMALITIES OF GAIT AND MOBILITY OTHER LACK OF COORDINATION DYSPHAGIA, OROPHARYNGEAL PHASE PRESSURE ULCER OF SACRAL REGION, UNSTAGEABLE
Zofran Oral Tablet 4 MG (Ondansetron HCl),Eliquis Oral Tablet 2.5 MG (Apixaban),Metoprolol Succinate ER Oral Tablet Extended Release 24 Hour 50 MG (Metoprolol Succinate),hydrALAZINE HCl Oral Tablet 25 MG (Hydralazine HCl)
NKA
N/A